UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide

Journal of the neurological sciences, 2020-09, Vol.416, p.117011-117011, Article 117011

2020

Volltextzugriff (PDF)

Durvalumab and multiple sclerosis: a causal link or simple unmasking?

European journal of clinical pharmacology, 2020-12, Vol.76 (12), p.1773-1774

2020

Volltextzugriff (PDF)

The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases

Frontiers in physiology, 2023-08, Vol.14, p.1241010-1241010

2023

Volltextzugriff (PDF)

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

Frontiers in neurology, 2024-07, Vol.15, p.1422078

2024

Volltextzugriff (PDF)

Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

Multiple sclerosis, 2023-06, Vol.29 (7), p.856-865

2023

Volltextzugriff (PDF)

A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP

Frontiers in psychology, 2022-08, Vol.13, p.965229-965229

2022

Volltextzugriff (PDF)

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics

Antioxidants, 2021-01, Vol.10 (1), p.21

2021

Volltextzugriff (PDF)

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register

Neurotherapeutics, 2021-04, Vol.18 (2), p.905-919

2021

Volltextzugriff (PDF)

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis

Multiple sclerosis, 2018-07, Vol.24 (8), p.1039-1045

2018

Volltextzugriff (PDF)

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Frontiers in immunology, 2019-06, Vol.10, p.1343-1343

2019

Volltextzugriff (PDF)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method

Frontiers in neurology, 2021-03, Vol.12, p.633115-633115

2021

Volltextzugriff (PDF)

PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels

Biomedicines, 2020-04, Vol.8 (4), p.85

2020

Volltextzugriff (PDF)

Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients

BMC Psychology, 2023-07, Vol.11 (1), p.208-208, Article 208

2023

Volltextzugriff (PDF)

Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients

Brain sciences, 2022-11, Vol.12 (12), p.1595

2022

Volltextzugriff (PDF)

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study

BMC neurology, 2012-12, Vol.12 (1), p.165-165, Article 165

2012

Volltextzugriff (PDF)

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

BMC neurology, 2012-10, Vol.12 (1), p.124-124, Article 124

2012

Volltextzugriff (PDF)

Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue

Brain sciences, 2021-04, Vol.11 (4), p.481

2021

Volltextzugriff (PDF)

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy

Brain sciences, 2020-08, Vol.10 (8), p.548

2020

Volltextzugriff (PDF)

An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study

JMIR serious games, 2023-01, Vol.11, p.e41371-e41371

2023

Volltextzugriff (PDF)

The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis

Farmeconomia. Health economics and therapeutic pathways, 2019-07, Vol.20 (1)

2019

Volltextzugriff (PDF)

Age-related disability in multiple sclerosis

Annals of neurology, 2002-04, Vol.51 (4), p.475-480

2002

Volltextzugriff (PDF)

Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?

Neurologic clinics, 2011-05, Vol.29 (2), p.309-321

2011

Volltextzugriff (PDF)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis

Biologics, 2009-01, Vol.3 (default), p.369-376

2009

Volltextzugriff (PDF)

Early considerations about the safety of cenobamate in the treatment of status epilepticus

Neurological sciences, 2024-07

2024

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals Current Collection

ThemaMedicine

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(83)
Berichte
(2)

Sprache

Englisch
(85)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(61)
Neurosciences & Neurology
(48)
Multiple Sclerosis
(44)
Clinical Neurology
(43)
Humans
(41)
Adult
(37)
Female
(35)
Neurosciences
(31)
Male
(28)
Middle Aged
(20)
Neurology
(17)
Multiple Sclerosis - Drug Therapy
(15)
Cohort Studies
(13)
Biological And Medical Sciences
(11)
Disability Evaluation
(11)
Medical Sciences
(11)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(11)
Follow-Up Studies
(10)
Interferon-Beta - Therapeutic Use
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide

Durvalumab and multiple sclerosis: a causal link or simple unmasking?

The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method

PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels

Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients

Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy

An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study

The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis

Age-related disability in multiple sclerosis

Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis

Early considerations about the safety of cenobamate in the treatment of status epilepticus

Aktive Filter

Suchergebnisse filtern